STING1 and neoplasm: The cGAS-STING signaling is also indispensable for the immune sensing of the immunogenic tumors, which ultimately induce the IFN-β production and activate dendritic cells, thus promoting the cross-priming of CD8+ T cells against tumor in vivo [40–42].